Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Arius3D Named SME Partner of the Year 2011

20 May 2011

Arius3D has been awarded Small and Medium Enterprise Partner of the Year for the long-standing collaborative work and research it has helped to develop, in particular with the Petrie Museum, who are using the company's scanning equipment to develop innovative exhibitions and displays.